[go: up one dir, main page]

GB201504223D0 - Biallelic genetic modification - Google Patents

Biallelic genetic modification

Info

Publication number
GB201504223D0
GB201504223D0 GB201504223A GB201504223A GB201504223D0 GB 201504223 D0 GB201504223 D0 GB 201504223D0 GB 201504223 A GB201504223 A GB 201504223A GB 201504223 A GB201504223 A GB 201504223A GB 201504223 D0 GB201504223 D0 GB 201504223D0
Authority
GB
United Kingdom
Prior art keywords
genetic modification
biallelic genetic
biallelic
modification
genetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201504223A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genome Research Ltd
Original Assignee
Genome Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genome Research Ltd filed Critical Genome Research Ltd
Priority to GB201504223A priority Critical patent/GB201504223D0/en
Publication of GB201504223D0 publication Critical patent/GB201504223D0/en
Priority to PCT/GB2016/050686 priority patent/WO2016142719A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GB201504223A 2015-03-12 2015-03-12 Biallelic genetic modification Ceased GB201504223D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB201504223A GB201504223D0 (en) 2015-03-12 2015-03-12 Biallelic genetic modification
PCT/GB2016/050686 WO2016142719A1 (en) 2015-03-12 2016-03-11 Biallelic genetic modification

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201504223A GB201504223D0 (en) 2015-03-12 2015-03-12 Biallelic genetic modification

Publications (1)

Publication Number Publication Date
GB201504223D0 true GB201504223D0 (en) 2015-04-29

Family

ID=53016040

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201504223A Ceased GB201504223D0 (en) 2015-03-12 2015-03-12 Biallelic genetic modification

Country Status (2)

Country Link
GB (1) GB201504223D0 (en)
WO (1) WO2016142719A1 (en)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10323236B2 (en) 2011-07-22 2019-06-18 President And Fellows Of Harvard College Evaluation and improvement of nuclease cleavage specificity
HRP20181648T1 (en) 2013-04-16 2019-01-25 Regeneron Pharmaceuticals, Inc. TARGET GENOMIC TARGET MODIFICATION
US9163284B2 (en) 2013-08-09 2015-10-20 President And Fellows Of Harvard College Methods for identifying a target site of a Cas9 nuclease
US9359599B2 (en) 2013-08-22 2016-06-07 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US9526784B2 (en) 2013-09-06 2016-12-27 President And Fellows Of Harvard College Delivery system for functional nucleases
US9322037B2 (en) 2013-09-06 2016-04-26 President And Fellows Of Harvard College Cas9-FokI fusion proteins and uses thereof
US9340799B2 (en) 2013-09-06 2016-05-17 President And Fellows Of Harvard College MRNA-sensing switchable gRNAs
MX388127B (en) 2013-12-11 2025-03-19 Regeneron Pharma METHODS AND COMPOSITIONS FOR THE TARGETED MODIFICATION OF A GENOME.
US20150165054A1 (en) 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting caspase-9 point mutations
CA2950173C (en) 2014-06-06 2023-10-10 Regeneron Pharmaceuticals, Inc. Methods and compositions for modifying a targeted locus
US10077453B2 (en) 2014-07-30 2018-09-18 President And Fellows Of Harvard College CAS9 proteins including ligand-dependent inteins
EP3204496A1 (en) 2014-10-10 2017-08-16 Editas Medicine, Inc. Compositions and methods for promoting homology directed repair
PL3207124T3 (en) 2014-10-15 2019-11-29 Regeneron Pharma Methods and compositions for generating or maintaining pluripotent cells
WO2016073990A2 (en) 2014-11-07 2016-05-12 Editas Medicine, Inc. Methods for improving crispr/cas-mediated genome-editing
ES2731437T3 (en) 2014-11-21 2019-11-15 Regeneron Pharma Methods and compositions for directed genetic modification through the use of guide RNA pairs
US11667911B2 (en) 2015-09-24 2023-06-06 Editas Medicine, Inc. Use of exonucleases to improve CRISPR/CAS-mediated genome editing
US10167457B2 (en) 2015-10-23 2019-01-01 President And Fellows Of Harvard College Nucleobase editors and uses thereof
EP3433363A1 (en) 2016-03-25 2019-01-30 Editas Medicine, Inc. Genome editing systems comprising repair-modulating enzyme molecules and methods of their use
WO2017180694A1 (en) 2016-04-13 2017-10-19 Editas Medicine, Inc. Cas9 fusion molecules gene editing systems, and methods of use thereof
CN113831407B (en) 2016-05-20 2024-06-11 瑞泽恩制药公司 Methods for breaking immune tolerance using multiple guide RNAs
WO2017207589A1 (en) 2016-06-01 2017-12-07 Kws Saat Se Hybrid nucleic acid sequences for genome engineering
KR20250103795A (en) 2016-08-03 2025-07-07 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 Adenosine nucleobase editors and uses thereof
EP3497214B1 (en) 2016-08-09 2023-06-28 President and Fellows of Harvard College Programmable cas9-recombinase fusion proteins and uses thereof
WO2018039438A1 (en) 2016-08-24 2018-03-01 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
AU2017342543B2 (en) 2016-10-14 2024-06-27 President And Fellows Of Harvard College AAV delivery of nucleobase editors
US10745677B2 (en) 2016-12-23 2020-08-18 President And Fellows Of Harvard College Editing of CCR5 receptor gene to protect against HIV infection
EA201991809A1 (en) * 2017-01-30 2020-02-05 КВС ЗААТ СЕ & КО. КГаА MATRIX CLUTCH FOR REPAIR WITH ENDONUCLEASES FOR GENOMIC ENGINEERING
EP3592853A1 (en) 2017-03-09 2020-01-15 President and Fellows of Harvard College Suppression of pain by gene editing
US12390514B2 (en) 2017-03-09 2025-08-19 President And Fellows Of Harvard College Cancer vaccine
US11542496B2 (en) 2017-03-10 2023-01-03 President And Fellows Of Harvard College Cytosine to guanine base editor
BR112019019655A2 (en) 2017-03-23 2020-04-22 Harvard College nucleobase editors comprising nucleic acid programmable dna binding proteins
WO2018209320A1 (en) 2017-05-12 2018-11-15 President And Fellows Of Harvard College Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
US11866726B2 (en) 2017-07-14 2024-01-09 Editas Medicine, Inc. Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites
US11732274B2 (en) 2017-07-28 2023-08-22 President And Fellows Of Harvard College Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE)
CN111278848B (en) 2017-08-04 2023-06-27 北京大学 TALE RVD for specifically recognizing methylation modified DNA base and application thereof
CN111278983A (en) 2017-08-08 2020-06-12 北京大学 gene knockout method
US11319532B2 (en) 2017-08-30 2022-05-03 President And Fellows Of Harvard College High efficiency base editors comprising Gam
AU2018352592C1 (en) 2017-10-16 2025-09-25 Beam Therapeutics, Inc. Uses of adenosine base editors
US12406749B2 (en) 2017-12-15 2025-09-02 The Broad Institute, Inc. Systems and methods for predicting repair outcomes in genetic engineering
CN108048537A (en) * 2017-12-25 2018-05-18 三峡大学 DNA molecular probe and the application detected to miRNA real-time quantitative PCRs in the tumour cell of S1 nucleases
CN110343724B (en) * 2018-04-02 2021-10-12 北京大学 Method for screening and identifying functional lncRNA
US12157760B2 (en) 2018-05-23 2024-12-03 The Broad Institute, Inc. Base editors and uses thereof
US12522807B2 (en) 2018-07-09 2026-01-13 The Broad Institute, Inc. RNA programmable epigenetic RNA modifiers and uses thereof
WO2020092453A1 (en) 2018-10-29 2020-05-07 The Broad Institute, Inc. Nucleobase editors comprising geocas9 and uses thereof
US12351837B2 (en) 2019-01-23 2025-07-08 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
CN114127285B (en) 2019-03-19 2024-09-10 布罗德研究所股份有限公司 Methods and compositions for editing nucleotide sequences
EP3956349A1 (en) 2019-04-17 2022-02-23 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
CN110564774B (en) * 2019-08-23 2021-10-15 华南农业大学 A method to improve the efficiency of site-directed modification of cellular genome by using modified ssODN
US12435330B2 (en) 2019-10-10 2025-10-07 The Broad Institute, Inc. Methods and compositions for prime editing RNA
DE112021002672T5 (en) 2020-05-08 2023-04-13 President And Fellows Of Harvard College METHODS AND COMPOSITIONS FOR EDIT BOTH STRANDS SIMULTANEOUSLY OF A DOUBLE STRANDED NUCLEOTIDE TARGET SEQUENCE
CN116926072B (en) * 2023-05-04 2024-03-08 广州飞来爱生命科技有限公司 Method for inhibiting neural stem cell induced differentiation and application thereof

Also Published As

Publication number Publication date
WO2016142719A1 (en) 2016-09-15

Similar Documents

Publication Publication Date Title
GB201504223D0 (en) Biallelic genetic modification
SMT202100520T1 (en) Genetic construct
GB201707959D0 (en) No details
ZA201802462B (en) Gene therapy
DK3298030T3 (en) Anti-cancerfusionspolypeptid
DK3373882T3 (en) Patientisolator
GB201706130D0 (en) No details
GB201615071D0 (en) No details
GB201612542D0 (en) no details
GB201709180D0 (en) No details
IL257500A (en) Modified cullin1 gene
GB201517241D0 (en) DNA modification
GB201616225D0 (en) No details
GB201601250D0 (en) No details present
GB2541867B (en) Polytunnel arrangement
GB201708207D0 (en) No details
GB2545956B (en) Vibro-polishing arrangement
GB2540412B (en) Polytunnel arrangement
GB201702336D0 (en) No details
GB2544388B (en) Polytunnel Arrangement
GB201608944D0 (en) Gene Tharapy
GB201614498D0 (en) No details
AU5511P (en) PTK647 Epichloe coenophiala
GB201521840D0 (en) No details
GB201617092D0 (en) No details

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)